Efficacy
Tumors, Tumor
TUMORS, SOLID TUMORS, TUMOR
Efficacy assessments occurred at screening (baseline scan) and on Day 15 of every third cycle with a ±2‐day window. Tumor status was assessed by the investigator using appropriate disease‐specific techniques. For solid tumors, the Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 criteria were used,